Defective interfering viruses and their impact on vaccines and viral vectors

被引:52
作者
Frensing, Timo [1 ,2 ]
机构
[1] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, D-39106 Magdeburg, Germany
[2] Otto Von Guericke Univ, Cellular Syst Bioproc Engn, Magdeburg, Germany
关键词
Defective interfering particles; Influenza virus; Viral vaccines; Viral vectors; Virus production; SEMLIKI-FOREST-VIRUS; INFLUENZA-VIRUS; MEASLES-VIRUS; WILD-TYPE; IN-VIVO; VESICULAR STOMATITIS; GENE-EXPRESSION; INFECTED-CELLS; T-PARTICLES; DI RNAS;
D O I
10.1002/biot.201400429
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Defective interfering particles (DIPs) have been found for many important viral pathogens and it is believed that most viruses generate DIPs. This article reviews the current knowledge of the generation and amplification of DIPs, which possess deletions in the viral genome but retain the ability to replicate in the presence of a complete helper virus. In addition, mechanisms are discussed by which DIPs interfere with the replication of their helper virus leading to the production of mainly progeny DIPs by coinfected cells. Even though DIPs cannot replicate on their own, they are biologically active and it is well known that they have a huge impact on virus replication, evolution, and pathogenesis. Moreover, defective genomes are potent inducers of the innate immune response. Yet, little attention has been paid to DIPs in recent years and their impact on biotechnological products such as vaccines and viral vectors remains elusive in most cases. With a focus on influenza virus, this review demonstrates that DIPs are important for basic research on viruses and for the production of viral vaccines and vectors. Reducing the generation and/or amplification of DIPs ensures reproducible results as well as high yields and consistent product quality in virus production.
引用
收藏
页码:681 / U56
页数:11
相关论文
共 71 条
[1]   Bioprocess optimization for cell culture based influenza vaccine production [J].
Aggarwal, Kunal ;
Jing, Frank ;
Maranga, Luis ;
Liu, Jonathan .
VACCINE, 2011, 29 (17) :3320-3328
[2]   EXPRESSION OF DEFECTIVE-INTERFERING INFLUENZA VIRUS-SPECIFIC TRANSCRIPTS AND POLYPEPTIDES IN INFECTED-CELLS [J].
AKKINA, RK ;
CHAMBERS, TM ;
NAYAK, DP .
JOURNAL OF VIROLOGY, 1984, 51 (02) :395-403
[3]   The Structure of Native Influenza Virion Ribonucleoproteins [J].
Arranz, Rocio ;
Coloma, Rocio ;
Javier Chichon, Francisco ;
Javier Conesa, Jose ;
Carrascosa, Jose L. ;
Valpuesta, Jose M. ;
Ortin, Juan ;
Martin-Benito, Jaime .
SCIENCE, 2012, 338 (6114) :1634-1637
[4]   The growth of attenuated influenza vaccine donor strains in continuous cell lines [J].
Audsley, JM ;
Tannock, GA .
JOURNAL OF VIROLOGICAL METHODS, 2005, 123 (02) :187-193
[5]  
BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55
[6]   ATTENUATION OF WILD-TYPE YELLOW-FEVER VIRUS BY PASSAGE IN HELA-CELLS [J].
BARRETT, ADT ;
MONATH, TP ;
CROPP, CB ;
ADKINS, JA ;
LEDGER, TN ;
GOULD, EA ;
SCHLESINGER, JJ ;
KINNEY, RM ;
TRENT, DW .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :2301-2306
[7]   WIDE OCCURRENCE OF MEASLES-VIRUS SUBGENOMIC RNAS IN ATTENUATED LIVE-VIRUS VACCINES [J].
BELLOCQ, C ;
MOTTET, G ;
ROUX, L .
BIOLOGICALS, 1990, 18 (04) :337-343
[8]   GENERATION OF MEASLES-VIRUS DEFECTIVE INTERFERING PARTICLES AND THEIR PRESENCE IN A PREPARATION OF ATTENUATED LIVE-VIRUS VACCINE [J].
CALAIN, P ;
ROUX, L .
JOURNAL OF VIROLOGY, 1988, 62 (08) :2859-2866
[9]  
Dimmock N. J., 1991, REV MED VIROL, V1, P165, DOI DOI 10.1002/RMV.1980010306)
[10]   Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals? [J].
Dimmock, Nigel J. ;
Easton, Andrew J. .
JOURNAL OF VIROLOGY, 2014, 88 (10) :5217-5227